Financials data is unavailable for this security.
View more
Year on year Trans Genic Inc grew revenues 14.47% from 11.43bn to 13.08bn while net income improved from a loss of 409.67m to a gain of 4.09m.
Gross margin | 16.64% |
---|---|
Net profit margin | -1.32% |
Operating margin | -1.70% |
Return on assets | -1.60% |
---|---|
Return on equity | -2.95% |
Return on investment | -2.28% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at Trans Genic Inc fell by 993.35m. Cash Flow from Investing was negative at 280.93m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 392.45m for operations while cash used for financing totalled 342.69m.
Cash flow per share | -0.4401 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 346.44 |
---|---|
Tangible book value per share | 307.28 |
More ▼
Balance sheet in JPYView more
Current ratio | 2.04 |
---|---|
Quick ratio | 1.32 |
Total debt/total equity | 0.4983 |
---|---|
Total debt/total capital | 0.3286 |
More ▼